Nuclera Nucleics Company
Nuclera is a next-generation DNA synthesis company creating tailored solutions for the synthetic biology, industrial enzyme engineering, and pharmaceutical industries. Our proprietary enzyme-mediated DNA synthesis platform will enable the rapid and cost-effective production of highly accurate, ultra-long DNA strands. We aim to be the key provider of long-length variant DNA and genome libraries for protein, biological pathway, and ultimately genome-scale engineering.
Headquarters:
Cambridge
Funding Status:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Research
Investor Type:
N/A
Founded Date:
2013
Industry:
Personalized Medicine